Glucos B. Braun (Glucose Monohydrate)

Glucos B. Braun is employed in clinical settings where intravenous carbohydrate delivery is required.

• Parenteral nutrition for patients unable to receive enteral feeding.
• Acute treatment of hypoglycemia when oral glucose is not feasible.
• Fluid and electrolyte replacement as part of balanced IV therapy.
• Energy source during peri‑operative fasting or critical illness.
• Support for metabolic demands in burn or trauma patients.
• Adjunct in neonatal intensive care for glucose maintenance.

When administered intravenously, Glucos B. Braun may be associated with a range of observed effects, most of which are related to the infusion itself or to rapid changes in blood glucose.

Common

• Transient hyperglycemia or hypoglycemia depending on infusion rate.
• Local irritation or pain at the injection site.
• Mild electrolyte shifts, particularly sodium or potassium.
• Nausea or feeling of fullness during rapid infusion.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Hypoglycemic coma if glucose falls abruptly after infusion stops.
• Fluid overload causing pulmonary edema.
• Allergic reaction such as urticaria or anaphylaxis.

Clinicians should observe specific precautions when prescribing Glucos B. Braun to minimize risks and ensure appropriate therapeutic outcomes.

• Verify patient’s baseline blood glucose and adjust infusion rate accordingly.
• Assess fluid balance and cardiac function to avoid overload.
• Use aseptic technique to prevent contamination of the IV solution.
• Monitor electrolytes, especially sodium, potassium, and phosphate, during prolonged therapy.
• Consider reduced concentrations in neonates and infants.
• Avoid use in patients with known hypersensitivity to glucose preparations.
• Document infusion parameters and patient response in the medical record.

Glucos B. Braun can interact with other intravenous agents or systemic medications, influencing glucose homeostasis or fluid status.

Avoid

• Concurrent high‑dose insulin infusions without close glucose monitoring.
• Co‑administration with other hypertonic dextrose solutions that may cause severe hyperglycemia.
• Use with potassium‑rich solutions in patients at risk of hyperkalemia without electrolyte checks.

Use with caution

• Simultaneous administration of diuretics that may alter fluid balance.
• Combination with corticosteroids that increase glucose production.
• Co‑infusion with calcium‑containing solutions, which may precipitate if mixed improperly.